USEUOTHERClinicalTrials.govClinical trial
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Phase 3RecruitingJul 31, 2026
Cancer types
Ovarian Cancer
Incl. platinum-resistant disease. 62 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 62 of 62
Highlight terms:
USClinicalTrials.govClinical trial
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 1Active, not recruitingJul 31, 2026
CNClinicalTrials.govClinical trial
Clinical Research Cohort for Polycystic Ovary Syndrome
Active, not recruitingJul 31, 2026
CNClinicalTrials.govClinical trial
Development and Clinical Application of ApoC3 Protein as a Predictive Biomarker for Insulin Resistance in Polycystic Ovary Syndrome
Active, not recruitingJul 31, 2026
EUClinicalTrials.govClinical trial
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours
Phase 1RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 2Active, not recruitingJul 31, 2026
EUClinicalTrials.govClinical trial
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
Not applicableActive, not recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women
Not yet recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 2/3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Active, not recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries
RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Phase 2RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
Phase 1RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 3Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer
Phase 1/2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Phase 1Active, not recruitingJul 31, 2026
USEUClinicalTrials.govClinical trial
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/2RecruitingJul 30, 2026
USEUOTHERClinicalTrials.govClinical trial
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Phase 2RecruitingJul 30, 2026
OTHERClinicalTrials.govClinical trial
Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS)
Not yet recruitingJul 30, 2026
USEUClinicalTrials.govClinical trial
Clinical Pre-screening Protocol for Ovarian Cancer
RecruitingJul 30, 2026
CNClinicalTrials.govClinical trial
Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia
RecruitingJul 30, 2026
OTHERClinicalTrials.govClinical trial
Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome
Not yet recruitingJul 30, 2026
USCNOTHERClinicalTrials.govClinical trial
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
Phase 1Active, not recruitingJul 30, 2026
EUOTHERClinicalTrials.govClinical trial
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
Phase 1/2RecruitingJul 30, 2026
USClinicalTrials.govClinical trial
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2RecruitingJul 30, 2026
USClinicalTrials.govClinical trial
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Not yet recruitingJul 29, 2026
USClinicalTrials.govClinical trial
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
Not applicableRecruitingJul 29, 2026
USEUCNOTHERClinicalTrials.govClinical trial
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
Phase 3Active, not recruitingJul 29, 2026
EUClinicalTrials.govClinical trial
Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1RecruitingJul 29, 2026
USClinicalTrials.govClinical trial
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
RecruitingJul 29, 2026
USClinicalTrials.govClinical trial
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Phase 1Active, not recruitingJul 29, 2026
CNCDERegulatory
CDE 临床试验默示许可 — clinical trial implied licence notices
Continuously updated
CNCDERegulatory
CDE 优先审评公示 — priority review listings
Continuously updated
CNCDERegulatory
CDE 受理品种信息 — applications accepted for review
Continuously updated
CNCDEGuideline
CDE 指导原则 — published technical guidance documents
Continuously updated
CNCDERegulatory
CDE 突破性治疗公示 — breakthrough therapy designation notices
Continuously updated
CNCDERegulatory
CDE 附条件批准品种 — conditionally approved products list
Continuously updated
CNChiCTRRegistry
ChiCTR — Chinese Clinical Trial Registry, public search
Continuously updated
EUCTISRegistry
CTIS public register — search clinical trials authorised in the EU/EEA
Continuously updated
EUEMARegulatory
EMA — CHMP meeting highlights and opinions on new medicines
Continuously updated
EUEMARegulatory
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Continuously updated
EUEMARegulatory
EMA — searchable database of authorised medicines in the EU
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — gynaecological cancers
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — public index by tumour type
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — supportive and palliative care section
Continuously updated
USFDARegulatory
FDA — expanded access (compassionate use) information for patients
Continuously updated
USFDARegulatory
FDA — oncology (cancer) / hematologic malignancies approval notifications
Continuously updated
USFDARegulatory
FDA — ongoing accelerated approvals for oncology indications
Continuously updated
USNCCNGuideline
NCCN Guidelines — palliative care category listing
Continuously updated
USNCCNGuideline
NCCN Guidelines — public index by cancer type (free registration)
Continuously updated
USNCCNGuideline
NCCN Guidelines for Patients — plain-language versions
Continuously updated
CNNMPARegulatory
NMPA 药品 — national drug approval announcements
Continuously updated
CNCDERegistry
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Continuously updated
This site does not provide medical advice
TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.